Chembio Diagnostics (CEMI) Misses Q3 EPS by 2c

Chembio Diagnostics (NASDAQ: CEMI) reported Q3 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $3.75 million versus the consensus estimate of $3.76 million.

For earnings history and earnings-related data on Chembio Diagnostics (CEMI) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c